fluconazole has been researched along with arachidonic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| El-Kadi, AO; El-Sherbeni, AA | 1 |
| Alammari, AH; El-Kadi, AOS; Maayah, ZH; Shoieb, SM | 1 |
| Albertyn, J; Cason, E; Fourie, R; Kuloyo, O; Pohl, CH | 1 |
4 other study(ies) available for fluconazole and arachidonic acid
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism.
Topics: Arachidonic Acid; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Drug Repositioning; Fluconazole; Humans; Microsomes, Liver; Resveratrol; Spectrometry, Mass, Electrospray Ionization; Stilbenes | 2016 |
Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 Enzyme System; Fluconazole; Rats; Rats, Sprague-Dawley | 2020 |
Transcriptome Analyses of
Topics: Antifungal Agents; Arachidonic Acid; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Pharmaceutical Preparations | 2020 |